Paronychia
Showing 1 - 25 of 1,044
Patients Who Received EGFR-TKI for the Treatment of NSCLC and Developed Paronychia (Affecting Fingernails, Toenails or Both)
Recruiting
- Patients Who Received EGFR-TKI for the Treatment of Non-small Cell Lung Cancer and Developed Paronychia (Affecting Fingernails, Toenails or Both)
- Topical Timolol
-
Hong Kong, Hong KongQueen Mary Hospital
Nov 14, 2023
Paronychia, Epidermal Growth Factor Receptor Inhibitor Trial in Taipei (Timolol maleate 0.5% ophthalmic solution, Cryotherapy
Recruiting
- Paronychia
- Epidermal Growth Factor Receptor Inhibitor
- Timolol maleate 0.5% ophthalmic solution
- Cryotherapy with liquid nitrogen
-
Taipei, TaiwanTaipei Municipal Wan-Fang Hospital
Jun 7, 2022
Acneiform Eruption Due to Chemical, Xerosis Cutis, Paronychia Trial (HT-001 2% Topical Gel, HT-001 1% Topical Gel, HT-001 0.5%
Not yet recruiting
- Acneiform Eruption Due to Chemical
- +2 more
- HT-001 2% Topical Gel
- +3 more
- (no location specified)
Dec 3, 2022
NSCLC Trial (Amivantamab, Lazertinib, Doxycycline)
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- Amivantamab
- +6 more
- (no location specified)
Nov 7, 2023
Chemo-Associated Paronychia Trial in United States (VBP-926)
Completed
- Chemotherapy-Associated Paronychia
-
Fountain Valley, California
- +7 more
Jan 23, 2019
Metastatic Colorectal Cancer, Cetuximab, Skin Toxicity Trial in Guangzhou (Crisaborole Ointment, Cetuximab)
Recruiting
- Metastatic Colorectal Cancer
- +2 more
- Crisaborole Ointment
- Cetuximab
-
Guangzhou, Guangdong, ChinaWeiWei Xiao
Nov 3, 2023
Non-dermatophyte Onychomycosis Trial in Bangkoknoi (1,064nm Long-pulsed Nd:YAG, Amorolfine)
Completed
- Non-dermatophyte Onychomycosis
- 1,064nm Long-pulsed Nd:YAG
- Amorolfine
-
Bangkoknoi, Bangkok, ThailandDepartment of Dermatology Siriraj Hospital
Sep 24, 2021
Human Papillomavirus (HPV)-Related Malignancies, Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related Malignancies
Completed
- Human Papillomavirus (HPV)-Related Malignancies
- Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related Malignancies
-
Basking Ridge, New Jersey
- +5 more
Dec 14, 2022
Colorectal Cancer Metastatic, Skin Toxicity Trial in Milano (Lycopene, Placebo)
Active, not recruiting
- Colorectal Cancer Metastatic
- Skin Toxicity
- Lycopene
- Placebo
-
Milano, ItalyMarco Pirovano
Sep 8, 2021
NSCLC Trial in Australia, China, Korea, Republic of (AZD9291)
Active, not recruiting
- Non-Small Cell Lung Cancer
-
Kogarah, Australia
- +29 more
Oct 20, 2022
CTCL Trial in New York (StrataCTX® gel)
Recruiting
- CTCL
- StrataCTX® gel
-
New York, New YorkColumbia University Medical Center, Department of Dermatology
Aug 3, 2021
Waldenstrom Macroglobulinemia Trial in Japan (Ibrutinib, Rituximab)
Active, not recruiting
- Waldenstrom Macroglobulinemia
-
Chiba, Japan
- +8 more
Jan 27, 2023
Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small Lymphocytic Lymphoma Trial in China
Completed
- Relapsed or Refractory Chronic Lymphocytic Leukemia
- Relapsed or Refractory Small Lymphocytic Lymphoma
-
Beijing, Beijing, China
- +15 more
Sep 29, 2021
Non Small Cell Lung Cancer Trial in Worldwide (AZD9291)
Active, not recruiting
- Non Small Cell Lung Cancer
-
La Jolla, California
- +43 more
Nov 25, 2022
Waldenstrom's Macroglobulinemia Trial in Boston (Ibrutinib)
Completed
- Waldenstrom's Macroglobulinemia
-
Boston, Massachusetts
- +1 more
Dec 5, 2022
Recurrent Colorectal Carcinoma, Stage IVA Colorectal Cancer, Stage IVB Colorectal Cancer Trial in Buffalo, Cleveland (Cetuximab,
Completed
- Recurrent Colorectal Carcinoma
- +2 more
- Cetuximab
- +2 more
-
Buffalo, New York
- +1 more
Sep 29, 2022
Gastrinoma, Glucagonoma, Insulinoma Trial in United States (regorafenib, laboratory biomarker analysis)
Completed
- Gastrinoma
- +8 more
- regorafenib
- laboratory biomarker analysis
-
Scottsdale, Arizona
- +4 more
Nov 15, 2021
Colorectal Tumors Trial in Philadelphia (bevacizumab, cetuximab, Oxaliplatin)
Terminated
- Colorectal Neoplasms
- bevacizumab
- +3 more
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Dec 30, 2021
Non Small Cell Lung Cancer (NSCLC) Trial in India (Osimertinib)
Completed
- Non Small Cell Lung Cancer (NSCLC)
-
Hyderabad, India
- +6 more
May 10, 2021
Head and Neck Squamous Cell Carcinoma, Colorectal Cancer, Non Small Cell Lung Cancer Trial in Lyon (Cicaplast Balm B5, Dexeryl)
Completed
- Head and Neck Squamous Cell Carcinoma
- +3 more
- Cicaplast Balm B5
- Dexeryl
-
Lyon, Rhône, FranceCentre Léon Bérard
Jul 8, 2021
Early Stage Breast Cancer Trial in United States (Paclitaxel, Neulasta)
Completed
- Early Stage Breast Cancer
-
Boston, Massachusetts
- +3 more
Apr 11, 2022
Multiple Sclerosis Trial in Worldwide (Interferon beta-1a, Fingolimod, Placebo capsule)
Recruiting
- Multiple Sclerosis
- Interferon beta-1a
- +3 more
-
Birmingham, Alabama
- +106 more
Jan 13, 2023
Crohn's Disease Trial in Japan (E6011 2 mg/kg, E6011 5 mg/kg, E6011 10 mg/kg)
Completed
- Crohn's Disease
- E6011 2 mg/kg
- +3 more
-
Nagoya, Aichi, Japan
- +16 more
Apr 28, 2022
GIOTRIF rPMS in Korean Patients With NSCLC
Completed
- Carcinoma, Non-Small-Cell Lung
- GIOTRIF 20mg
- +2 more
-
Multiple Locations, Korea, Republic of(unnamed)
Feb 5, 2021